Multiple Antigen-Engineered DC Vaccine for Melanoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Lisa H. Butterfield, Ph.D., University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01622933
First received: June 14, 2012
Last updated: December 1, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)